Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ellenbogen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
BMJ Open|October 28, 2021
Response to cardiac resynchronisation therapy in men and women: a secondary analysis of the SMART-AV randomised controlled trialStacey Howell, Timothy M Stivland, Kenneth Stein, et al.
ESC Heart Failure|May 24, 2024
Safety and efficacy of adaptive atrial pacing regulated by blood pressure during low-level exercise: a proof-of-concept studyMichael Burnam, Robert Develle, Leo Polosajian, et al.
Pacing and Clinical Electrophysiology : PACE|December 14, 2011
Acute clinical evaluation of a left ventricular automatic threshold determination algorithm based on evoked response sensingGautham Kalahasty, Michael Giudici, John Lobban, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 15, 2023
Tackling Health Care Disparities: How to Build a Sarcoidosis CenterJordana Kron, Aamer Syed, Thomas Iden, et al.
American Heart Journal|May 13, 2015
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) studyGregory Y H Lip, Jose Merino, Michael Ezekowitz, et al.
The American Surgeon|August 14, 2025
Structured Workflow to Manage Periprocedural Code Status for Patients With Do-Not-Resuscitate OrdersCarrie Fisher, Danielle Noreika, Kyeong Ri Yu, et al.
American Heart Journal|October 3, 2002
Health values before and after pacemaker implantationFrancisco Lopez-Jimenez, Lee Goldman, E John Orav, et al.
International Journal of Cardiology|March 14, 2013
Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practiceZachary I Whinnett, Darrel P Francis, Arnaud Denis, et al.
JACC. Clinical Electrophysiology|February 8, 2023
Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY TrialJose Osorio, Ayman A Hussein, M Craig Delaughter, et al.
Journal of Cardiovascular Electrophysiology|October 23, 2023
Paroxysmal atrial fibrillation ablation with a novel temperature-controlled CF-sensing catheter: Q-FFICIENCY clinical and healthcare utilization benefitsAyman A Hussein, M Craig Delaughter, George Monir, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BMJ Open|October 28, 2021
Response to cardiac resynchronisation therapy in men and women: a secondary analysis of the SMART-AV randomised controlled trialStacey Howell, Timothy M Stivland, Kenneth Stein, et al.
ESC Heart Failure|May 24, 2024
Safety and efficacy of adaptive atrial pacing regulated by blood pressure during low-level exercise: a proof-of-concept studyMichael Burnam, Robert Develle, Leo Polosajian, et al.
Pacing and Clinical Electrophysiology : PACE|December 14, 2011
Acute clinical evaluation of a left ventricular automatic threshold determination algorithm based on evoked response sensingGautham Kalahasty, Michael Giudici, John Lobban, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 15, 2023
Tackling Health Care Disparities: How to Build a Sarcoidosis CenterJordana Kron, Aamer Syed, Thomas Iden, et al.
American Heart Journal|May 13, 2015
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) studyGregory Y H Lip, Jose Merino, Michael Ezekowitz, et al.
The American Surgeon|August 14, 2025
Structured Workflow to Manage Periprocedural Code Status for Patients With Do-Not-Resuscitate OrdersCarrie Fisher, Danielle Noreika, Kyeong Ri Yu, et al.
American Heart Journal|October 3, 2002
Health values before and after pacemaker implantationFrancisco Lopez-Jimenez, Lee Goldman, E John Orav, et al.
International Journal of Cardiology|March 14, 2013
Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practiceZachary I Whinnett, Darrel P Francis, Arnaud Denis, et al.
JACC. Clinical Electrophysiology|February 8, 2023
Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY TrialJose Osorio, Ayman A Hussein, M Craig Delaughter, et al.
Journal of Cardiovascular Electrophysiology|October 23, 2023
Paroxysmal atrial fibrillation ablation with a novel temperature-controlled CF-sensing catheter: Q-FFICIENCY clinical and healthcare utilization benefitsAyman A Hussein, M Craig Delaughter, George Monir, et al.
Pageof 3